SNB-101 (SN-38)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SNB-101 (SN-38), covering 2026-01-27 to 2026-01-27. Get the full timeline:
Most recent: Clinical Trial Update: Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors [Phase 1]